Wells David B reported option exercise involving 1,051 shares of Hims Hers Health, Inc. on Nov 13, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
1,051Class A Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
230,859Direct
Trade date
Nov 13, 2026Option exercise
Filed
Nov 17, 2026, 4:16 PM ET4-day reporting delay
Accession
0001507645-26-000004Code M · Transaction 403324
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Option exercise1,051$0.00$0Trade 403325
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

HIMS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HIMS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +58%1w ago +48%1d ago +12%
Returns since7d30d90d180d1y

Footnotes in full

F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $30,000 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.